We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFFN icon
1001
Capitol Federal Financial
CFFN
$1.1B
$752K ﹤0.01%
57,108
+23,410
+69% +$303K
TTM
1002
DELISTED
Tata Motors Limited
TTM
$752K ﹤0.01%
+38,453
New +$909K
VRE
1003
DELISTED
Veris Residential
VRE
$751K ﹤0.01%
37,040
+7,688
+26% +$142K
ZYNE
1004
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$744K ﹤0.01%
+76,339
New +$782K
NAAS
1005
NaaS Technology Inc
NAAS
$59M
$739K ﹤0.01%
7
+1
+17% +$124K
GE icon
1006
GE Aerospace
GE
$384B
$738K ﹤0.01%
11,315
-442,314
-98% -$29.5M
IIIV icon
1007
i3 Verticals
IIIV
$342M
$737K ﹤0.01%
+48,408
New +$771K
WLY icon
1008
John Wiley & Sons Class A
WLY
$2.66B
$734K ﹤0.01%
+11,766
New +$781K
CNR
1009
Core Natural Resources Inc
CNR
$4.45B
$734K ﹤0.01%
19,146
-293,554
-94% -$11.3M
KMI icon
1010
Kinder Morgan
KMI
$68.7B
$732K ﹤0.01%
41,400
-84,260
-67% -$1.38M
MNR
1011
DELISTED
Monmouth Real Estate Investment Corp
MNR
$731K ﹤0.01%
+44,231
New +$685K
LXFR icon
1012
Luxfer Holdings
LXFR
$458M
$717K ﹤0.01%
+41,023
New +$657K
NKE icon
1013
Nike
NKE
$61.9B
$717K ﹤0.01%
8,997
-507,764
-98% -$35.8M
SAIC icon
1014
Saic
SAIC
$5.35B
$714K ﹤0.01%
8,825
-11,689
-57% -$993K
FITB
1015
Fifth Third Bancorp
FITB
$51.8B
$713K ﹤0.01%
+24,849
New +$789K
TVRD
1016
Tvardi Therapeutics
TVRD
$23.4M
$707K ﹤0.01%
+1,026
New +$522K
LGTY
1017
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$703K ﹤0.01%
+48,240
New +$650K
CORE
1018
DELISTED
Core Mark Holding Co., Inc.
CORE
$702K ﹤0.01%
+30,943
New +$636K
INFI
1019
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$701K ﹤0.01%
367,031
-414,305
-53% -$837K
MAXR
1020
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$697K ﹤0.01%
13,900
-98,023
-88% -$4.63M
ZUO
1021
DELISTED
Zuora, Inc.
ZUO
$691K ﹤0.01%
+25,398
New +$601K
AMRN
1022
Amarin Corp
AMRN
$303M
$678K ﹤0.01%
10,976
-4,596
-30% -$285K
CMTL icon
1023
Comtech Telecommunications
CMTL
$51.8M
$674K ﹤0.01%
21,127
+6,362
+43% +$199K
LONE
1024
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
$674K ﹤0.01%
+79,857
New +$503K
CSR
1025
Centerspace
CSR
$952M
$671K ﹤0.01%
+12,125
New +$661K
39 40
41
42 43

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.